ADARx Pharmaceuticals, Inc. [ADRX] - ADARx Pharmaceuticals IPO

ADARx Pharmaceuticals, Inc. is offering 26,250,000 shares at an initial public offering price of $17.00 per share, aiming for gross proceeds of approximately $446.25 million, with expected proceeds of $415.01 million after underwriting discounts.

View source filing ↗